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Introduction and Aims: The last decade have shown that FGF23 and Klotho may have
relevant independent actions on the renal and cardiovascular systems. They interfere
with vascular functions and may play a role in vascular calcification, atherosclerosis
and arteriolosclerosis. On the other hand, pulse pressure is a well-known risk factor of
cardiovascular morbidity and mortality in renal patients. The aim of this study is to
investigate the relationship between FGF-23 and Klotho with pulse pressure in type 2
diabetic with chronic kidney disease (CKD) stages 2-3.
Methods: In a observational study we included 107 type 2 diabetic patients with
chronic kidney disease (CKD) stages 2- 3, followed in our outpatient Diabetic Kidney
Clinic. We used descriptive statistics, the Student´s t and the chi-square tests. We also
divided our population according to the pulse pressure, G I <50 mmHg (n=79) and G2
≥ 50 mmHg (n=61), and we compared these groups regarding the several biological
and laboratorial parameters analyzed. We employed a multiple regression model to
identify risk factors of increased pulse pressure (PP). In this model we used as
dependent variable the pulse pressure, and as independent ones age, mineral
metabolism parameters, urine albumin-to-creatinine ratio, insulin resistance, oxidative
stress, eGFR, FGF-23 and Klotho levels.
Results: The mean age of these patients was 59.6 years, the mean eGFR (MDRD) was
43.5ml/min and 37.4% (40) were female. We found that G2 patients showed higher age
(p=0.017), phosphorus (p=0.0001), iPTH (p=0.0001), urine albumin-to-creatinine
ratio (p=0.001), Homa-IR (p=0.001), FGF-23 (p=0.0001) and OxLDL (p=0.0001) and
lower levels of eGFR (p=0.0001), Klotho (p=0.0001) and 25(OH)2D3 (p=0.0001). In
the multivariate linear regression model we found that FGF-23 (β=0.377, p=0.047) and
the Klotho (β= - 0.567, p=0.023) are independent risk factors for increasing the pulse
pressure.
Conclusions: In a population of type 2 diabetic with chronic kidney disease stages 2-3,
the Klotho and FGF-23 levels are independently associated with PP. Further studies
with more patients and with medical intervention are warranted to confirm whether an
increase in Klotho and a decrease in FGF-23 would reduce the PP and consequently
the cardiovascular risk of our patients.
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